Bridgeway Capital Management’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-29,830
| Closed | -$93.4K | – | 1402 |
|
|
2023
Q2 | $93.4K | Hold |
29,830
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q1 | $101K | Hold |
29,830
| – | – | ﹤0.01% | 1237 |
|
|
2022
Q4 | $134K | Hold |
29,830
| – | – | ﹤0.01% | 1171 |
|
|
2022
Q3 | $263K | Hold |
29,830
| – | – | 0.01% | 1078 |
|
|
2022
Q2 | $343K | Buy |
29,830
+13,120
| +79% | +$151K | 0.01% | 966 |
|
|
2022
Q1 | $292K | Hold |
16,710
| – | – | 0.01% | 1089 |
|
|
2021
Q4 | $541K | Sell |
16,710
-8,000
| -32% | -$259K | 0.01% | 961 |
|
|
2021
Q3 | $991K | Sell |
24,710
-12,650
| -34% | -$507K | 0.02% | 834 |
|
|
2021
Q2 | $613K | Sell |
37,360
-6,450
| -15% | -$106K | 0.01% | 1013 |
|
|
2021
Q1 | $832K | Buy |
43,810
+19,110
| +77% | +$363K | 0.02% | 928 |
|
|
2020
Q4 | $556K | Buy |
24,700
+3,200
| +15% | +$72K | 0.01% | 909 |
|
|
2020
Q3 | $426K | Buy |
21,500
+8,200
| +62% | +$162K | 0.01% | 957 |
|
|
2020
Q2 | $278K | Buy |
+13,300
| New | +$278K | 0.01% | 1062 |
|
|
2019
Q4 | – | Sell |
-3,630
| Closed | -$42K | – | 1358 |
|
|
2019
Q3 | $42K | Hold |
3,630
| – | – | ﹤0.01% | 1282 |
|
|
2019
Q2 | $65K | Hold |
3,630
| – | – | ﹤0.01% | 1269 |
|
|
2019
Q1 | $68K | Hold |
3,630
| – | – | ﹤0.01% | 1301 |
|
|
2018
Q4 | $73K | Hold |
3,630
| – | – | ﹤0.01% | 1324 |
|
|
2018
Q3 | $283K | Hold |
3,630
| – | – | ﹤0.01% | 1262 |
|
|
2018
Q2 | $327K | Hold |
3,630
| – | – | ﹤0.01% | 1234 |
|
|
2018
Q1 | $301K | Hold |
3,630
| – | – | ﹤0.01% | 1205 |
|
|
2017
Q4 | $227K | Hold |
3,630
| – | – | ﹤0.01% | 1260 |
|
|
2017
Q3 | $211K | Hold |
3,630
| – | – | ﹤0.01% | 1274 |
|
|
2017
Q2 | $236K | Hold |
3,630
| – | – | ﹤0.01% | 1255 |
|
|
2017
Q1 | $333K | Buy |
+3,630
| New | +$333K | ﹤0.01% | 1184 |
|